keyword
https://read.qxmd.com/read/38618410/thymoma-exhibiting-spontaneous-regression-with-cystic-change-due-to-acute-infarction-a-case-report-and-literature-review
#1
Mikito Suzuki, Reiko Shimizu, Masahiko Harada, Tsunekazu Hishima, Hirotoshi Horio
Spontaneous regression (SR) of thymoma is rare. We report a case of a surgically resected thymoma due to cystic changes owing to acute ischemic infarction with an increased anti-acetylcholine receptor antibody level. A 61-year-old male underwent a computed tomography (CT) scan, which showed a 4.9 cm anterior mediastinal tumor and slight right pleural effusion. Blood test results indicated an elevated white blood cell count of 13300/mL. One month later, an enhanced CT scan at our hospital showed spontaneous mediastinal tumor regression to 3...
March 2024: Curēus
https://read.qxmd.com/read/38617537/influence-of-microbiota-on-tumor-immunotherapy
#2
REVIEW
Xin Yu, Wenge Li, Zhi Li, Qi Wu, Shengrong Sun
The role of the microbiome in immunotherapy has recently garnered substantial attention, with molecular studies and clinical trials providing emerging evidence on the pivotal influence of the microbiota in enhancing therapeutic outcomes via immune response modulation. However, the impact of microbial communities can considerably vary across individuals and different immunotherapeutic approaches, posing prominent challenges in harnessing their potential. In this comprehensive review, we outline the current research applications in tumor immunotherapy and delve into the possible mechanisms through which immune function is influenced by microbial communities in various body sites, encompassing those in the gut, extraintestinal barrier, and intratumoral environment...
2024: International Journal of Biological Sciences
https://read.qxmd.com/read/38617245/irf8-driven-reprogramming-of-the-immune-microenvironment-enhances-anti-tumor-adaptive-immunity-and-reduces-immunosuppression-in-murine-glioblastoma
#3
Megan Montoya, Sara A Collins, Pavlina Chuntova, Trishna S Patel, Takahide Nejo, Akane Yamamichi, Noriyuki Kasahara, Hideho Okada
BACKGROUND: Glioblastoma (GBM) has a highly immunosuppressive tumor immune microenvironment (TIME), largely mediated by myeloid-derived suppressor cells (MDSCs). Here, we utilized a retroviral replicating vector (RRV) to deliver Interferon Regulatory Factor 8 (IRF8), a master regulator of type 1 conventional dendritic cell (cDC1) development, in a syngeneic murine GBM model. We hypothesized that RRV-mediated delivery of IRF8 could "reprogram" intratumoral MDSCs into antigen-presenting cells (APCs) and thereby restore T-cell responses...
April 3, 2024: bioRxiv
https://read.qxmd.com/read/38617241/regulation-of-fatty-acid-delivery-to-metastases-by-tumor-endothelium
#4
Deanna N Edwards, Shan Wang, Wenqiang Song, Laura C Kim, Verra M Ngwa, Yoonha Hwang, Kevin C Ess, Mark R Boothby, Jin Chen
Tumor metastasis, the main cause of death in cancer patients, requires outgrowth of tumor cells after their dissemination and residence in microscopic niches. Nutrient sufficiency is a determinant of such outgrowth 1 . Fatty acids (FA) can be metabolized by cancer cells for their energetic and anabolic needs but impair the cytotoxicity of T cells in the tumor microenvironment (TME) 2, 3 , thereby supporting metastatic progression. However, despite the important role of FA in metastatic outgrowth, the regulation of intratumoral FA is poorly understood...
April 3, 2024: bioRxiv
https://read.qxmd.com/read/38617153/hemodynamic-property-incorporated-brain-tumor-segmentation-by-deep-learning-and-density-based-analysis-of-dynamic-susceptibility-contrast-enhanced-magnetic-resonance-imaging-mri
#5
JOURNAL ARTICLE
Leonardo Tang, Tianhe Wu, Ranliang Hu, Quanquan Gu, Xiaofeng Yang, Hui Mao
BACKGROUND: Magnetic resonance imaging (MRI) is a primary non-invasive imaging modality for tumor segmentation, leveraging its exceptional soft tissue contrast and high resolution. Current segmentation methods typically focus on structural MRI, such as T1 -weighted post-contrast-enhanced or fluid-attenuated inversion recovery (FLAIR) sequences. However, these methods overlook the blood perfusion and hemodynamic properties of tumors, readily derived from dynamic susceptibility contrast (DSC) enhanced MRI...
April 3, 2024: Quantitative Imaging in Medicine and Surgery
https://read.qxmd.com/read/38616190/anti-lymphangiogenesis-for-boosting-drug-accumulation-in-tumors
#6
JOURNAL ARTICLE
Chunling Wang, Junchao Xu, Xiaoyu Cheng, Ge Sun, Fenfen Li, Guangjun Nie, Yinlong Zhang
The inadequate tumor accumulation of anti-cancer agents is a major shortcoming of current therapeutic drugs and remains an even more significant concern in the clinical prospects for nanomedicines. Various strategies aiming at regulating the intratumoral permeability of therapeutic drugs have been explored in preclinical studies, with a primary focus on vascular regulation and stromal reduction. However, these methods may trigger or facilitate tumor metastasis as a tradeoff. Therefore, there is an urgent need for innovative strategies that boost intratumoral drug accumulation without compromising treatment outcomes...
April 15, 2024: Signal Transduction and Targeted Therapy
https://read.qxmd.com/read/38615875/unveiling-intratumoral-microbiota-an-emerging-force-for-colorectal-cancer-diagnosis-and-therapy
#7
REVIEW
Jinjing Zhang, Penghui Wang, Jiafeng Wang, Xiaojie Wei, Mengchuan Wang
Microbes, including bacteria, viruses, fungi, and other eukaryotic organisms, are commonly present in multiple organs of the human body and contribute significantly to both physiological and pathological processes. Nowadays, the development of sequencing technology has revealed the presence and composition of the intratumoral microbiota, which includes Fusobacterium, Bifidobacteria, and Bacteroides, and has shed light on the significant involvement in the progression of colorectal cancer (CRC). Here, we summarized the current understanding of the intratumoral microbiota in CRC and outline the potential translational and clinical applications in the diagnosis, prevention, and treatment of CRC...
April 12, 2024: Pharmacological Research: the Official Journal of the Italian Pharmacological Society
https://read.qxmd.com/read/38614528/prognostic-value-of-brain-perfusion-by-mri-in-the-initial-study-of-high-grade-gliomas
#8
JOURNAL ARTICLE
F Fernández-Valverde, M P Bautista-Bárcena, E Roldán-Romero, J Solivera-Vela, F Bravo-Rodríguez, M J Ramos-Gómez
OBJECTIVES: To evaluate if the tumour perfusion at the initial MRI scan is a marker of prognosis for survival in patients diagnosed with High Grade Gliomas (HGG). To analyse the risk factors which influence on the mortality from HGG to quantify the overall survival to be expected in patients. PATIENTS AND METHODS: The patients diagnosed with HGG through a MRI scan in a third-level hospital between 2017 and 2019 were selected. Clinical and tumour variables were collected...
2024: Radiología
https://read.qxmd.com/read/38614095/macrophage-coated-tumor-cluster-aggravates-hepatoma-invasion-and-immunotherapy-resistance-via-generating-local-immune-deprivation
#9
JOURNAL ARTICLE
Junya Ning, Yingnan Ye, Hongru Shen, Runjiao Zhang, Huikai Li, Tianqiang Song, Rui Zhang, Pengpeng Liu, Guidong Chen, Hailong Wang, Fenglin Zang, Xiangchun Li, Jinpu Yu
Immune checkpoint inhibitors (ICIs) represent a promising treatment for hepatocellular carcinoma (HCC) due to their capacity for abundant lymphocyte infiltration. However, some patients with HCC respond poorly to ICI therapy due to the presence of various immunosuppressive factors in the tumor microenvironment. Our research reveals that a macrophage-coated tumor cluster (MCTC) signifies a unique spatial structural organization in HCC correlating with diminished recurrence-free survival and overall survival in a total of 572 HCC cases from 3 internal cohorts and 2 independent external validation cohorts...
April 9, 2024: Cell reports medicine
https://read.qxmd.com/read/38614094/a-comprehensive-single-cell-breast-tumor-atlas-defines-epithelial-and-immune-heterogeneity-and-interactions-predicting-anti-pd-1-therapy-response
#10
JOURNAL ARTICLE
Lily Xu, Kaitlyn Saunders, Shao-Po Huang, Hildur Knutsdottir, Kenneth Martinez-Algarin, Isabella Terrazas, Kenian Chen, Heather M McArthur, Julia Maués, Christine Hodgdon, Sangeetha M Reddy, Evanthia T Roussos Torres, Lin Xu, Isaac S Chan
We present an integrated single-cell RNA sequencing atlas of the primary breast tumor microenvironment (TME) containing 236,363 cells from 119 biopsy samples across eight datasets. In this study, we leverage this resource for multiple analyses of immune and cancer epithelial cell heterogeneity. We define natural killer (NK) cell heterogeneity through six subsets in the breast TME. Because NK cell heterogeneity correlates with epithelial cell heterogeneity, we characterize epithelial cells at the level of single-gene expression, molecular subtype, and 10 categories reflecting intratumoral transcriptional heterogeneity...
April 9, 2024: Cell reports medicine
https://read.qxmd.com/read/38613913/results-from-the-united-study-a-multicenter-study-validating-the-prognostic-effect-of-the-tumor-stroma-ratio-in-colon-cancer
#11
JOURNAL ARTICLE
M Polack, M A Smit, G W van Pelt, A G H Roodvoets, E Meershoek-Klein Kranenbarg, H Putter, H Gelderblom, A S L P Crobach, V Terpstra, G Petrushevska, G Gašljević, S Kjær-Frifeldt, E M V de Cuba, N W J Bulkmans, G R Vink, R Al Dieri, R A E M Tollenaar, J H J M van Krieken, W E Mesker
BACKGROUND: The TNM (tumor-node-metastasis) Evaluation Committee of Union for International Cancer Control (UICC) and College of American Pathologists (CAP) recommended to prospectively validate the cost-effective and robust tumor-stroma ratio (TSR) as an independent prognostic parameter, since high intratumor stromal percentages have previously predicted poor patient-related outcomes. PATIENTS AND METHODS: The 'Uniform Noting for International application of Tumor-stroma ratio as Easy Diagnostic tool' (UNITED) study enrolled patients in 27 participating centers in 12 countries worldwide...
April 12, 2024: ESMO Open
https://read.qxmd.com/read/38613483/liposomal-phenylephrine-nanoparticles-enhance-the-antitumor-activity-of-intratumoral-chemotherapy-in-a-preclinical-model-of-melanoma
#12
JOURNAL ARTICLE
Emmanuel M Gabriel, Deborah Bahr, Hari Krishnareddy Rachamala, Vijay S Madamsetty, Barath Shreeder, Sanjay Bagaria, Amber L Escobedo, Joel M Reid, Debabrata Mukhopadhyay
Intratumoral injection of anticancer agents has limited efficacy and is not routinely used for most cancers. In this study, we aimed to improve the efficacy of intratumoral chemotherapy using a novel approach comprising peri-tumoral injection of sustained-release liposomal nanoparticles containing phenylephrine, which is a potent vasoconstrictor. Using a preclinical model of melanoma, we have previously shown that systemically administered (intravenous) phenylephrine could transiently shunt blood flow to the tumor at the time of drug delivery, which in turn improved antitumor responses...
April 13, 2024: ACS Biomaterials Science & Engineering
https://read.qxmd.com/read/38612457/enhanced-therapeutic-potential-of-hybrid-exosomes-loaded-with-paclitaxel-for-cancer-therapy
#13
JOURNAL ARTICLE
Xuan Wang, Dongdong Li, Gaotian Li, Jinda Chen, Yi Yang, Lijun Bian, Jingying Zhou, Yongge Wu, Yan Chen
The advancement of exosome studies has positioned engineered exosomes as crucial biomaterials for the development of advanced drug delivery systems. This study focuses on developing a hybrid exosome system by fusing mesenchymal stem cells (MSCs) exosomes with folate-targeted liposomes. The aim was to improve the drug loading capacity and target modification of exosome nanocarriers for delivering the first-line chemotherapy drug paclitaxel (PTX) and its effectiveness was assessed through cellular uptake studies to evaluate its ability to deliver drugs to tumor cells in vitro...
March 25, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612436/immune-cytolytic-activity-and-strategies-for-therapeutic-treatment
#14
REVIEW
Stephanie Agioti, Apostolos Zaravinos
Intratumoral immune cytolytic activity (CYT), calculated as the geometric mean of granzyme-A (GZMA) and perforin-1 (PRF1) expression, has emerged as a critical factor in cancer immunotherapy, with significant implications for patient prognosis and treatment outcomes. Immune checkpoint pathways, the composition of the tumor microenvironment (TME), antigen presentation, and metabolic pathways regulate CYT. Here, we describe the various methods with which we can assess CYT. The detection and analysis of tumor-infiltrating lymphocytes (TILs) using flow cytometry or immunohistochemistry provide important information about immune cell populations within the TME...
March 23, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611661/susceptibility-weighted-mri-for-predicting-nf-2-mutations-and-s100-protein-expression-in-meningiomas
#15
JOURNAL ARTICLE
Sena Azamat, Buse Buz-Yalug, Sukru Samet Dindar, Kubra Yilmaz Tan, Alpay Ozcan, Ozge Can, Ayca Ersen Danyeli, M Necmettin Pamir, Alp Dincer, Koray Ozduman, Esin Ozturk-Isik
S100 protein expression levels and neurofibromatosis type 2 (NF-2) mutations result in different disease courses in meningiomas. This study aimed to investigate non-invasive biomarkers of NF-2 copy number loss and S100 protein expression in meningiomas using morphological, radiomics, and deep learning-based features of susceptibility-weighted MRI (SWI). This retrospective study included 99 patients with S100 protein expression data and 92 patients with NF-2 copy number loss information. Preoperative cranial MRI was conducted using a 3T clinical MR scanner...
March 31, 2024: Diagnostics
https://read.qxmd.com/read/38611634/clinical-epidemiological-morphological-and-immunohistochemical-aspects-of-nasopharyngeal-carcinoma-4-year-retrospective-study-in-the-western-part-of-romania
#16
JOURNAL ARTICLE
Maria Alina Marin, Raluca-Maria Closca, Aurel Marin, Marina Rakitovan, Adrian Nicoara, Marioara Poenaru, Marius Militaru, Flavia Baderca
Nasopharyngeal carcinoma is one of the most common malignant tumors in the head and neck region. The carcinogenesis is a complex process stimulated by many factors. Although the etiological factors and pathogenic mechanisms are not elucidated, the genetic susceptibility, environmental factors, and association with latent infection with Epstein-Barr Virus play an important role. The aim of this study was to present the main clinical and epidemiological data, as well as the morphological aspects and the immunohistochemical profile, of patients with nasopharyngeal carcinoma diagnosed in western Romania...
March 29, 2024: Diagnostics
https://read.qxmd.com/read/38609101/dual-molecule-targeting-hdac6-leads-to-intratumoral-cd4-cytotoxic-lymphocytes-recruitment-through-mhc-ii-upregulation-on-lung-cancer-cells
#17
JOURNAL ARTICLE
Sarah Ducellier, Mélanie Demeules, Boris Letribot, Massimiliano Gaetani, Chloé Michaudel, Harry Sokol, Abdallah Hamze, Mouad Alami, Mégane Nascimento, Sébastien Apcher
BACKGROUND: Despite the current therapeutic treatments including surgery, chemotherapy, radiotherapy and more recently immunotherapy, the mortality rate of lung cancer stays high. Regarding lung cancer, epigenetic modifications altering cell cycle, angiogenesis and programmed cancer cell death are therapeutic targets to combine with immunotherapy to improve treatment success. In a recent study, we uncovered that a molecule called QAPHA ((E)-3-(5-((2-cyanoquinolin-4-yl)(methyl)amino)-2-methoxyphenyl)-N-hydroxyacrylamide) has a dual function as both a tubulin polymerization and HDAC inhibitors...
April 11, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38608697/sonogenetics-controlled-synthetic-designer-cells-for-cancer-therapy-in-tumor-mouse-models
#18
JOURNAL ARTICLE
Tian Gao, Lingxue Niu, Xin Wu, Di Dai, Yang Zhou, Mengyao Liu, Ke Wu, Yuanhuan Yu, Ningzi Guan, Haifeng Ye
Bacteria-based therapies are powerful strategies for cancer therapy, yet their clinical application is limited by a lack of tunable genetic switches to safely regulate the local expression and release of therapeutic cargoes. Rapid advances in remote-control technologies have enabled precise control of biological processes in time and space. We developed therapeutically active engineered bacteria mediated by a sono-activatable integrated gene circuit based on the thermosensitive transcriptional repressor TlpA39 ...
April 5, 2024: Cell reports medicine
https://read.qxmd.com/read/38608514/intratumoral-cd38-cd19-b-cells-associate-with-poor-clinical-outcomes-and-immunosuppression-in-patients-with-pancreatic-ductal-adenocarcinoma
#19
JOURNAL ARTICLE
Heng Zhu, Jin Xu, Wei Wang, Bo Zhang, Jiang Liu, Chen Liang, Jie Hua, Qingcai Meng, Xianjun Yu, Si Shi
BACKGROUND: The widespread involvement of tumor-infiltrating B cells highlights their potential role in tumor behavior. However, B cell heterogeneity in PDAC remains unexplored. Studying TIL-Bs in PDAC aims to identify new treatment strategies. METHODS: We performed single-cell RNA sequencing to study the heterogeneity of B cells in PDAC. The prognostic and immunologic value of the identified CD38+ B cells was explored in FUSCC (n = 147) and TCGA (n = 176) cohorts...
April 11, 2024: EBioMedicine
https://read.qxmd.com/read/38607250/molecular-pathology-of-small-cell-lung-cancer-overview-from-studies-on-neuroendocrine-differentiation-regulated-by-ascl1-and-notch-signaling
#20
REVIEW
Takaaki Ito
Pulmonary neuroendocrine (NE) cells are rare airway epithelial cells. The balance between Achaete-scute complex homolog 1 (ASCL1) and hairy and enhancer of split 1, one of the target molecules of the Notch signaling pathway, is crucial for NE differentiation. Small cell lung cancer (SCLC) is a highly aggressive lung tumor, characterized by rapid cell proliferation, a high metastatic potential, and the acquisition of resistance to treatment. The subtypes of SCLC are defined by the expression status of NE cell-lineage transcription factors, such as ASCL1, which roles are supported by SRY-box 2, insulinoma-associated protein 1, NK2 homeobox 1, and wingless-related integration site signaling...
April 12, 2024: Pathology International
keyword
keyword
71972
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.